Lvqiulun

Dr. Lu, a professor of pharmacokinetics at China Pharmaceutical University, possesses a profound interest in advancing our comprehension of metabolic processes and drug behavior, particularly within the realms of cardiovascular and cerebrovascular pharmacokinetics. With a diverse background spanning both basic science and clinical medicine, he boasts specialized training and proficiency in pathophysiology and molecular biology, and revolves around the groundbreaking discovery and meticulous characterization of novel genes and natural products that play pivotal roles in diseases affecting the cardiovascular and nervous systems.

Deep learning-driven exploration of pyrroloquinoline quinone neuroprotective activity in Alzheimer’s disease. Advanced Sciences, 2024: 2308970

Dual roles of demethylation in cancer treatment and cardio-function recovery. Redox Biology, 2023, 64: 102785.

Epigenic modulation in the process of Alzheimer’s disease and cardiovascular diseases

Young Investigator Award (2017 China-USA Cardiovascular Symposium)